The official website of Zhong Lun Law Firm

Pharmaceuticals & Life Sciences

Zhong Lun has been delivering to clients services in the pharmaceuticals and life sciences sector informed by in-depth expertise and covering enter industry chains

We have a visionary and effective pharmaceutical and life sciences team consisting of dozens of top-notch lawyers with an ideal blend of expertise. Alongside their excellent commands of legal knowledge, they also possess solid expertise in medicine, medication, biology, and related fields. Such unique cross-disciplinary perspectives allow us to keenly understand the scientific and commercial principles that underpin state-of-the-art technologies like gene editing, cell therapy, and AI medicine development. By harnessing the distinctive discernment, we deliver solutions that encompass legal framework, scientific insights, and business acumen. Beyond counsel in the private sector, we have long been active in shaping national public policies in China’s healthcare sphere. Our close communication and sound rapport with key regulators inform our counseling, enabling us to deliver to our clients forward-thinking strategic compliance advice. We expertly navigate regulatory challenges and identify untapped commercial opportunities for our clients, transforming the landscape into a realm of unending possibilities.

We commit to provide one-stop, comprehensive legal services in the pharmaceuticals and life sciences sectors. Our extensive suite of services encompass key business stages in this realm, ranging from new medicine R&D, clinical trials, regulatory compliance in operation, intellectual property protection, domestic and overseas financing, and equity incentive plans, to M&A and restructuring, antitrust matters, dispute resolution, and capital market transactions such as listings. Beyond our established strengths, we have also accumulated a wealth of experience and successes in cutting-edge subsectors, including innovative medicine, medical devices, bioproducts, digital therapeutics, gene editing and testing, and processing of health data, among others.

Our clientele includes a diverse array of leading industry players and professional investment institutions both at home and abroad, and we have been instrumental in facilitating many landmark M&A, cross-border licensing transactions, and listings in both Chinese and overseas markets. Our outstanding capabilities have earned us widespread market recognition, as evidenced by consistent high rankings and recommendations from authoritative international legal media outlets and rating agencies, including Chambers, Legal 500, and asialaw.

Scope of Services

Merger and Acquisition

Advising on all aspects of domestic and cross-border equity or asset acquisition, spin-off, merger, MBO, and restructuring transactions

Scale-up and Technology Transactions in Life Sciences

Representing clients in both domestic and cross-border licensing and collaboration transactions

Private Equity and Venture Capital Investment

Advising investment institutions and startup companies on domestic and cross-border investment

Fund Formation

Reviewing limited partnership agreements, counselling on life sciences-focused investment funds, and acting as counsel for investors in such funds

Domestic and Overseas Capital Markets

Advising on IPOs and listings on both domestic and overseas stock exchanges, acquisition of listed companies, backdoor listings, refinancing of listed companies, and major asset restructuring of listed companies

Governance and Compliance

Developing and improving internal governance frameworks and rules for pharmaceutical and life science businesses and advising on the implementation of the same, with our services covering the entire operating process of pharmaceutical businesses, including industry access and regulation, product R&D and testing, interaction between pharmaceutical businesses and healthcare service providers, digital marketing, pharmacovigilance, and health data processing
Providing compliance training to the management, employees, and business partners in the pharmaceutical and life science sector
Negotiating contracts on behalf of clients with clinical trial sites, CROs, CDMOs, and CSOs during both clinical trial and commercialization stages

Regulatory Matters

Advising on administration and regulation of pharmaceuticals, medical devices, among others, including compliance of product R&D and clinical trials; product registration, manufacturing, distribution, packaging, and marketing; adverse events and product recall; tender; antitrust and price control

Compliance Investigations

Representing businesses in the pharmaceuticals and life sciences sector in response to criminal and administrative law enforcement actions by competent authorities; cooperating with overseas lawyers in response to anti-corruption and anti-bribery investigations conducted by overseas regulators; and conducting internal investigations of anti-commercial bribery, compliance reviews on business partners, and other compliance investigations for clients

Intellectual Property

Providing cross-regional, comprehensive, professional, and innovative services offered by our specialist teams working at offices in global metropolises such as Beijing, Shanghai, Shenzhen, Guangzhou, Chengdu, Wuhan, Hong Kong, London, New York, and Los Angeles, covering cross-border M&A, new drug launch, drug R&D, patent portfolio, transfer, cooperation, development, licensing, and intellectual property related dispute resolution

Dispute Resolution

Representing clients or delivering noncontentious solutions in disputes over investment and financing, licensing, distributorship agreements, general contractual issues, serious adverse events (SAEs) during clinical trials, compensation and indemnification; pharmaceutical product quality, drug adverse reactions, medical liability, and monopoly and unfair competition, among others

Articles

Deals

Awards